APTNOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
ADAPTIN BIO, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$6.27+0.00 (0.00%)
Close on Aug 19, 2026
- Market cap
- $55.48M
- P/E (TTM)
- –
- Dividend yield
- –
Adaptin Bio statistics
Financials through Jun 30, 2026, price-based ratios appear once a share price is available, median of Biological Products, (No Diagnostic Substances) companies for comparison
Income (trailing twelve months)
| Measure | Adaptin Bio | Industry median |
|---|---|---|
| Operating Income | -$5.39M | -$21.40M |
| Pretax Income | -$5.40M | -$14.34M |
| Net Income | -$5.40M | -$22.46M |
| EBITDA | -$5.39M | -$16.91M |
Returns
| Measure | Adaptin Bio | Industry median |
|---|---|---|
| Return on Assets (ROA) | -408.1% | -40.9% |
Balance sheet
| Measure | Adaptin Bio | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $670.49K | $61.43M |
| Net Cash (Debt) | $670.49K | $15.35M |
| Net Cash Per Share | $0.07 | $0.66 |
| Equity (Book Value) | -$1.67M | $49.09M |
| Book Value Per Share | -$0.18 | $1.37 |
| Tangible Book Value | -$1.67M | $23.52M |
| Working Capital | -$1.67M | $76.81M |
Financial position
| Measure | Adaptin Bio | Industry median |
|---|---|---|
| Current Ratio | 0.37 | 3.34 |
| Quick Ratio | 0.25 | 2.44 |
| Interest Coverage | -811.63 | -6.26 |
Cash flow (trailing twelve months)
| Measure | Adaptin Bio | Industry median |
|---|---|---|
| Operating Cash Flow | -$2.52M | -$12.35M |
Efficiency
| Measure | Adaptin Bio | Industry median |
|---|---|---|
| Profits Per Employee | -$1.35M | -$703.34K |
| Employee Count | 4 | 74 |
Shares
| Measure | Adaptin Bio | Industry median |
|---|---|---|
| Shares Outstanding | 9,233,570 | 58,127,000 |
| Shares Change (YoY) | 66.0% | 10.9% |
| Shares Change (QoQ) | 3.04% | 0.54% |
| Float | 2,895,530 | 49,136,700 |
| Shares Held by Insiders | 68.6% | 11.6% |
Scores
| Measure | Adaptin Bio | Industry median |
|---|---|---|
| Piotroski F-Score | 4 | 4 |
Calculated by StockData from Adaptin Bio's SEC filings. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.